Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Qiagen N.V. (NY: QGEN ) 41.02 -0.76 (-1.81%) Streaming Delayed Price Updated: 11:44 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Qiagen N.V. < Previous 1 2 3 4 5 6 Next > Strategic Buy Lights Up This Biotech Stock: Time to Invest? July 16, 2024 Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. Via MarketBeat FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation June 24, 2024 The FDA granted accelerated approval to Bristol Myers Squibb's Krazati (adagrasib) with cetuximab for adult patients with KRASG12C-mutated advanced or metastatic colorectal cancer. Via Benzinga Exposures Product Safety Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session June 20, 2024 Via Benzinga Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches June 17, 2024 QIAGEN announces a comprehensive growth strategy by 2028. The plan includes significant shareholder returns, new product launches, and a focus on digital and diagnostic advancements. Via Benzinga QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications May 30, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report May 06, 2024 According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far. Via Benzinga Topics Stocks Exposures US Equities Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. Via Benzinga Topics Stocks Exposures US Equities QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024 April 29, 2024 QGEN stock results show that Qiagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday? April 29, 2024 U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc.... Via Benzinga US Stocks Set To Approach New Week With Caution Ahead Of Fed Meeting, Tech Earnings: Analyst Says 'Buy The Dip' Contingent On This Condition April 29, 2024 U.S. stocks are looking to build on past week’s gains, with the mood remaining cautiously optimistic. The major index futures were modestly higher in early trading. Via Benzinga Topics Economy Exposures Interest Rates Earnings Scheduled For February 6, 2024 February 06, 2024 Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. Via Benzinga Earnings Preview: Qiagen February 05, 2024 Via Benzinga Where Qiagen Stands With Analysts December 07, 2023 Via Benzinga Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion January 17, 2024 Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing... Via Benzinga Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects January 03, 2024 QIAGEN N.V. (NYSE: QGEN) disclosed its expansion plan in Via Benzinga Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock December 07, 2023 Qiagen NV (NYSE: QGEN) has a steady income from selling tools for preparing samples and diagnostics. Via Benzinga These Companies Helped The German DAX Index Hit Its All-time High December 06, 2023 The DAX 40 index surged to its all-time high on Tuesday, continuing the remarkable rally that started on October 23rd. The index, which tracks the 40 biggest companies in Germany, soared to a high of... Via Talk Markets Analyst Expectations for Qiagen's Future November 02, 2023 Via Benzinga Preview: Qiagen's Earnings October 27, 2023 Via Benzinga Analyst Expectations for Qiagen's Future October 17, 2023 Via Benzinga Will Chart Analysts Notice Bad Omen on Qiagen's Chart April 11, 2023 Via Benzinga Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends October 31, 2023 Qiagen NV's (NASDAQ: QGEN) Q3 net sales of $470 million at constant exchange rates (CER) for Q3 2023 were above the outlook for at least $465 million CER, driven by 5% CER growth in the Via Benzinga QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer October 26, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year September 21, 2023 In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. Via Benzinga Exposures COVID-19 Earnings Scheduled For October 30, 2023 October 30, 2023 Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement July 26, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 September 12, 2023 Via Benzinga The 3 Most Promising Biotech Stocks to Buy Now March 21, 2023 With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. Via InvestorPlace QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results March 13, 2023 From QIAGEN N.V. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.